Pharmaceutical Business review

Response Genetics to secure $2 million in private placement

The company has entered into a purchase agreement with certain affiliated funds of Special Situations Funds to raise $2 million from the private placement of two million newly issued shares of its common stock, at a purchase price of $1 per share.

According to the company, the closing of the sale of the shares is expected to occur on March 2, 2009.